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Iridium(III) complexes of 1,2,4-triazines as
potential bioorthogonal reagents: metal
coordination facilitates luminogenic reaction with
strained cyclooctynes†
Valery N. Kozhevnikov, *a Michael E. Deary, b Theodora Mantso,a
Mihalis I. Panayiotidis‡a and Mark T. Simsa
In this paper we describe unprecedented Ir(III) complexes of 5-(2-
pyridyl)-1,2,4-triazine and their reactivity towards the strained
cyclooctyne BCN. The coordination of a 1,2,4-triazine ring to
an iridium(III) ion drastically increases the speed of the reaction,
showing the second order rate constant of 8 M1 s1, the record
value to date for a triazine-BCN reaction.
Bioorthogonal reactions occur in living systems without inter-
fering with intracellular processes and have found widespread
applications in biological sciences.1 The success of bioortho-
gonal chemistry is underpinned by the development of click
reactions and reagents that are designed to selectively react with
each other but not to react with any of the naturally present
molecules. Although this requirement is quite challenging, the
toolkit of bioorthogonal chemistry includes many reactions. One
of the fastest bioorthogonal reactions is the Inverse Electron
Demand Diels Alder (IEDDA) reaction of 1,2,4,5-tetrazines with
strained alkenes and alkynes.2 These reactions have now found
widespread applications in bioimaging and in a variety of other
fields.3 However, the most reactive tetrazines are also the least
stable under physiological conditions. Recently, 1,2,4-triazines
have been reported as potential bioorthogonal reagents oﬀering
excellent stability.4–11 Unfortunately, 1,2,4-triazines react much
slower in IEDDA reactions. Although it has been shown that
the kinetics can be improved by the introduction of electron-
withdrawing groups,9,10 the rate constant is two-three orders of
magnitude lower than for tetrazines.
Metal ions often catalyse IEDDA reactions by influencing the
frontier orbitals of the reactants and minimising the activation
energy of the reaction. For example Lo and co-workers have
recently shown that Ir(III) complexes of tetrazines react much
faster in IEDDA reactions than uncoordinated ligands.12 This
phenomenon inspired us to design metal complexes of 1,2,4-
triazines to improve the kinetics of the IEDDA reactions. In
addition, the result of the IEDDA reaction would be a polypyridine
type metal complex that often has attractive properties. For
example, we chose cyclometallated iridium(III) complexes because
they are among the brightest emitters used in bioimaging and
bioorthogonal chemistry.13,14,25 These complexes are easy to
prepare and photo-stable, and their photophysical properties,
such as absorption and emission, are highly tunable. The long-
lived emission of these complexes provides an opportunity for
the time-delayed elimination of background luminescence and
for phosphorescent lifetime imaging.15–23 In this paper we
report unprecedented Ir(III) complexes of 1,2,4-triazines as
luminogenic bioorthogonal reagents that react with BCN
much faster than the uncoordinated 1,2,4-triazine ligand
approaching the kinetic values of widely used tetrazines.
However, the relatively high toxicity of the complexes imposes
some limitations to bioorthogonality and further studies are
necessary to address this problem.
The key feature of our complexes is that the 1,2,4-triazine
ring is directly coordinated to the metal centre. Because during
the IEDDA reaction, the N1 and N2 atoms of the 1,2,4-triazine
ring are lost, the coordination to the metal should be through
the N4 atom. Only two isomers satisfy this criterion, and among
these, 5-(pyridine-2-yl)-1,2,4-triazine 1 is the best choice because
competitive coordination to the N2 atom of the triazine ring is
avoided (Fig. 1).
It should be noted that the ligand 1 has not been previously
reported and generally examples of N5 coordination are very rare
in the literature. Additional motivation for the use of isomer 1 is
that 5-substituted 1,2,4-triazines are the least sterically crowded
and able to react even with sterically encumbered strained
alkynes such as tetramethylthiacycloheptyne (TMTH).5 To pre-
pare the ligand 1, we first tested the most direct route by reacting
2-pyridineglyoxal 4 with formamidrazone24 but unfortunately,
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the reaction gave a mixture of two isomers 1 and 3 that we
could not separate either by recrystallization, or by column
chromatography. We therefore used another synthetic route,
depicted in Scheme 1. The route started with the reaction
of pyridine glyoxal 4 with thiosemicarbazide 5 to give selectively
3-mercapto triazine 6, which was then converted into the
hydrazine derivative 7, followed by dehydrazination by treatment
with sodium methoxide to give the desired ligand 1. Although the
overall yield was only 18%, this route is preferable because only the
desired 5-(2-pyridyl)-1,2,4-triazine 1 forms during the reaction. The
iridium(III) complex 8Cl was then prepared by the treatment of 1
with dichloro-bridged intermediate [Ir(dfppy)2Cl]2. It should be
noted that many other dichloro-bridged Ir(III) precursors can be
used at this stage, enabling the tuning of photophysical properties,
solubility and biocompatibility of the complexes.13,14 The chloride
salt 8Cl can be easily converted into a more hydrophobic hexa-
fluorophosphate analogue 8PF6 by treatment with excess sodium
hexafluorophosphate. While hexafluorophosphate salts are easier
to purify, chloride derivatives provide much better solubility in
water, a desirable feature for biological applications.
In the cellular environment, the concentrations of bio-
molecules are very low, demanding that the bioorthogonal
reactions should be very fast. For in vivo applications, the
rate constant should be in the order of 1 M1 s1 or higher.26
The reactions of 1,2,4-triazines with BCN show much slower
reaction rates.6 For example, we found that ligand 1 reacts with
BCN in methanol at 25 1C with a second order rate constant of
k2 = 0.059 M
1 s1. However, to our delight, we also found that
the coordination of the Ir(III) ion to the N4 atom of 1,2,4-triazine
increases the second order rate constant by more than two
orders of magnitude and the complex 8 shows the rate constant
of approximately 8 M1 s1 (Table 1). This is a very important
discovery that places the metal complexes of 1,2,4-triazines
kinetically in the same league as commonly used tetrazines.
In order to understand the influence of metal coordination
on the rate of the reaction, we performed computational
analysis. Calculated transition-state geometries for the reac-
tions of ligand 1 and complex 8 with BCN were found to exhibit
a similar distortion of the diene and similar positioning of the
alkyne C atoms of BCN ca. 2 Å from the C3 and C6 atoms of the
triazine ring. An example structure showing these features is
shown in Fig. 2 for complex 8 (Scheme 2).
Calculated Gibbs activation energies for reactions of 1 and 8
with BCN are given in Table 2. Also listed are the experimental
energy barriers determined from the observed rate constants.
The quantitative match between the calculated and experimental
values is similar to that reported in previous work studying organic
species, and a similar trend is exhibited of overestimating
the energy barriers when the activation energies are higher.27–29
Significantly, the calculations show amarked decrease in activation
energy on going from the free triazine ligand to the Ir coordinated
triazine, consistent with the experimental values.
Previous computational investigations of organic bioortho-
gonal reactions have shown the distortion–interaction model
Fig. 1 Possible (pyridine-2-yl)-1,2,4-triazines with green and red arrows
showing desirable and undesirable coordination respectively. Only 5-(pyridine-
2-yl)-1,2,4-triazine 1 avoids undesirable coordination and was chosen as
the most suitable ligand.
Scheme 1 The synthesis of 5-(pyridine-2-yl)-1,2,4-triazine 1 and its iridium(III)
complexes 8Cl and 8PF6.
Table 1 Second order rate constants, k2, for the reaction between the
triazine ligand and its iridium complexes and BCN in methanol at 25 1C
Compound k2/M
1 s1
1 0.059  0.001
8Cl 7.870  0.325
8PF6 8.223  0.307
Fig. 2 The lowest-energy transition state geometry calculated for the
reaction of 8 with BCN, calculated at the M06/6-311G(d,p)/LANL2DZ level.
Scheme 2 Reactions of iridium(III) complexes 8Cl or 8PF6 with BCN and
BCN-C10.
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to be a valuable tool in the interpretation of experimental
rate constants.4,27–30 In this model, individual energies of the
distortion of the reactant molecules from their minimum-energy
geometries to their transition state geometries are determined,
as well as the difference between the energies of the separated
reactant transition state geometries and that of the transition
state itself. Results of these analyses carried out for reactions of
BCN with 1 and 8 are shown in Fig. 2.
The calculated distortion energies of the triazines are both
significantly higher than those of BCN for the two transition
states, and there is only a small diﬀerence between the distortion
energies in the two reactions. In contrast, there is a large diﬀerence
between the calculated interaction energies for the reactions,
attributable to the lower calculated frontier orbital energy of
complex 8 (5.109 eV) than the ligand 1 (1.533 eV), making it
much closer to the energy of the BCN HOMO (7.197 eV) (Fig. 3).
Complex 8 shows a luminogenic response to reaction with
BCN. In bioimaging, the luminogenic probes that ‘‘switch on’’ only
after the conjugating click reaction takes place are particularly
important because the luminescent background of the non-
conjugated probe is not present and thus there is no need for
laborious and time-consuming washing steps. 8PF6 showed a
strong luminogenic behaviour in reaction with BCN-C10. While
the 8PF6 is virtually non-emissive in acetonitrile solution,
the addition of BCN-C10 leads to the appearance of intense
luminescence (Fig. 4B). The absorption also changes, which
can be registered visually as a transition from red to yellow
colour of the solution. The product of the IEDDA reaction is the
iridium bipyridine complex 9. Such complexes are well-studied
systems20 and by assuming that aliphatic substitution does not
drastically change the photophysical properties, one can pre-
dict that the quantum yield of the ‘‘switched-on’’ product 9 will
be in the region of 10–25% depending on the solvent used. In
general, the absorption and emission of cyclometallated Ir(III)
complexes such as 9 is highly tunable and can be adjusted to
desired values by the use of different sets of ligands. In-depth
photophysical investigation and tuning of these systems will be
reported in due course.
Because complexes can be potentially used in in vivo applica-
tions, it is important to assess their cytotoxicity. The cytotoxicity
profile of 8Cl was studied by performing the Alamar blue
cell viability assay in human malignant melanoma (A375) and
keratinocyte (HaCaT) cell lines. 8Cl was shown to be cytotoxic in
a dose-dependent manner at concentrations ranging from 5 to
100 mM over various incubation periods (24, 48, 72 h) in both cell
lines. Overall, HaCaT cells appeared to be more sensitive to 8Cl
when compared to A375 cells. The corresponding EC50 values
(half maximal eﬀective concentration) for diﬀerent incubation
periods were calculated and shown to be 32.9, 22.8 and 20.7 mM
for A375 cells, while they were considerably lower for HaCaT
cells at 17.5, 10.2 and 7.3 mM for 24, 48 and 72 h respectively.
High toxicity does not automatically mean that the complexes
are not suitable for in vivo biorthogonal experiments, rather
that care has to be taken to carry out such experiments using
concentrations that are nontoxic for the cells. Cytotoxicity
can also be significantly reduced in Ir complexes by ligand
modifications. For example it was shown that the introduction of
oligoethylene glycol chains significantly reduces cytotoxicity.14
While somewhat a barrier to bioorthogonality, high cytotoxicity
can potentially be exploited in the development of clickable
anticancer drugs. We are currently using other tumor cell lines
to demonstrate the cytotoxic eﬀect of the complexes before and
after click reaction in experimental models of skin cancer and
other solid tumors.
In summary, in this communication we have presented the
first example of 1,2,4-triazine metal complexes as dienophiles
in IEDDA reactions. We showed that the coordination to the
Ir(III) ion drastically increases the rate of the reaction with BCN.
Computational analysis indicates that complexation lowers the
energy of the reacting orbital, resulting in a more favourable
Table 2 Calculated (DG‡calc) and experimental (DG
‡
exp) Gibbs activation
energies for the reactions between the dienes and BCN
Diene DG‡calc/kcal mol
1 DG‡exp/kcal mol
1
1 26.4 19.1
8 20.7 16.2
Fig. 3 Calculated distortion energies, Edist, and interaction energies, Eint,
for reactions of ligand 1 and complex 8 with BCN, averaged over each of
the transition state geometries for each reaction.
Fig. 4 Visual appearance of acetonitrile solution of 8PF6 in (A) daylight
and (B) under UV (360 nm) irradiation before (left tube) and after (right
tube) the reaction with BCN-C10.
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interaction between the reactants that lowers the activation
energy. Because the ligands as well as the metal part of the
molecule can be varied, a great variety of 1,2,4-triazine metal
complexes can be prepared and their properties can be carefully
tuned for a particular application. This novel class of click
reagents is thus of interest to the field of bioorthogonal
chemistry and other scientific fields where metal-based func-
tionalisation is required.
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